Table 2.
Prognostic factor | OS | DFS |
---|---|---|
Age | ns | ns |
Gender | ns | ns |
WHO PS | ns | ns |
Tumour grade | ns | ns |
cTumour stagea | ns | ns |
cNodal stagea | ns | ns |
TRG | ns | ns |
TRG prognostic group | ns | ns |
pTumour staged | ns | ns |
pNodal staged | p = 0.005 | p = 0.039 |
pCRf | ||
Adjuvant chemotherapyg | ns | ns |
5-6 vs. ≤4 cycles* | p = 0.009 | p = 0.012 |
TRG = tumour regression grade23; WHO PS = WHO performance status
according the AJCC, 7th edition22
pathologic complete response
chemotherapy
calculated for 36 patients with indication for adjuvant chemotherapy; ns = not specific (p > 0.05).